Overview
Andrea Paradisi practices in Rome, Italy. Ms. Paradisi is rated as an Advanced expert by MediFind in the treatment of Benign Chronic Pemphigus. Her top areas of expertise are Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, Rhinophyma, and Benign Chronic Pemphigus.
Her clinical research consists of co-authoring 90 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Benign Chronic Pemphigus.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Basal Cell Skin CancerMs. Paradisi isDistinguished. Learn about Basal Cell Skin Cancer.
- Squamous Cell Skin CarcinomaMs. Paradisi isDistinguished. Learn about Squamous Cell Skin Carcinoma.
- Advanced
- Benign Chronic PemphigusMs. Paradisi isAdvanced. Learn about Benign Chronic Pemphigus.
- RhinophymaMs. Paradisi isAdvanced. Learn about Rhinophyma.
- Experienced
- Actinic KeratosisMs. Paradisi isExperienced. Learn about Actinic Keratosis.
- Anal CancerMs. Paradisi isExperienced. Learn about Anal Cancer.
- COVID-19Ms. Paradisi isExperienced. Learn about COVID-19.
- Erythema MultiformeMs. Paradisi isExperienced. Learn about Erythema Multiforme.
- FibrosarcomaMs. Paradisi isExperienced. Learn about Fibrosarcoma.
- Hidradenitis SuppurativaMs. Paradisi isExperienced. Learn about Hidradenitis Suppurativa.